Inhibition of the autocrine IL6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+breast cancers

被引：0
|
作者：
Silva, J.
Rodriguez-Barrueco, R.
Yu, J.
Kalinsky, K.
Maurer, M.
Califano, A.
机构：
[1] Mt Sinai Sch Med, New York, NY USA
[2] Columbia Univ, Nyc, NY USA
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-PD3-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD3-03
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers
    Wang, Q.
    Liu, P.
    Spangle, J. M.
    Von, T.
    Roberts, T. M.
    Lin, N. U.
    Krop, I. E.
    Winer, E. P.
    Zhao, J. J.
    ONCOGENE, 2016, 35 (27) : 3607 - 3612
  • [22] Characterizing the mechanism and the clinical relevance of the synthetic lethal interaction between STAT3 inhibition and HER2 overexpression in breast cancers
    Barrueco, Ruth Rodriguez
    Yu, Jiyang
    Alvarez, Mariano
    Castro, Veronica
    Marshall, Netonia
    Su, Ruoxi
    Castro, Laura
    Maurer, Matthew
    Califano, Andrea
    Silva, Jose M.
    CANCER RESEARCH, 2014, 74 (19)
  • [23] Characterizing the mechanism and the clinical relevance of the synthetic lethal interaction between STAT3 inhibition and HER2 overexpression in breast cancers
    Rodriguez-Barrueco, Ruth
    Yu, Jiyang
    Alvarez, Mariano
    Castro, Veronica
    Villagrasa, Patricia
    Marshall, Netonia
    Sun, Ruoxi
    Castro, Laura
    Califano, Andrea
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05)
  • [24] Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan
    Alaaeldin, Rania
    Ali, Fares E. M.
    Bekhit, Amany Abdlrehim
    Zhao, Qing-Li
    Fathy, Moustafa
    MOLECULES, 2022, 27 (22):
  • [25] Combination therapy of tanshinone IIA and puerarin for pulmonary fibrosis via targeting IL6-JAK2-STAT3/STAT1 signaling pathways
    Xue, Zhifeng
    Zhao, Fangzhe
    Sang, Xiaoqing
    Qiao, Yuchuan
    Shao, Rui
    Wang, Yuanyuan
    Gao, Shan
    Fan, Guanwei
    Zhu, Yan
    Yang, Jian
    PHYTOTHERAPY RESEARCH, 2021, 35 (10) : 5883 - 5898
  • [26] Inhibition of JAK2 blocks constitutive and IL-6-dependent STAT3 phosphorylation in a panel of solid tumor cell lines
    Gozgit, J.
    Bebernitz, G.
    Huszar, D.
    Zinda, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 43 - 43
  • [27] PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-6
    Zhong, Longzhu
    Tan, Wanlin
    Yang, Qianqiong
    Zou, Zhaowei
    Zhou, Rui
    Huang, Yongsheng
    Qiu, Zhenghua
    Zheng, Kehong
    Huang, Zonghai
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (06) : 2989 - 3008
  • [28] Targeted Therapy in HR+HER2-Metastatic Breast Cancer: Current Clinical Trials and Their Implications for CDK4/6 Inhibitor Therapy and beyond Treatment Options
    Elfgen, Constanze
    Bjelic-Radisic, Vesna
    CANCERS, 2021, 13 (23)
  • [29] Histone deacetylase (HDAC) 6 inhibition potentiates the cytotoxicity of lapatinib and PI3K inhibitors on Her2+breast cancer cell lines.
    Yang, Min
    Tamang, David
    Jones, Simon
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [30] IL-6/JAK2/STAT3 axis mediates neuropathic pain by regulating astrocyte and microglia activation after spinal cord injury
    Lee, Jee Youn
    Park, Chan Sol
    Seo, Kyung Jin
    Kim, In Yi
    Han, Sungmin
    Youn, Inchan
    Yune, Tae Young
    EXPERIMENTAL NEUROLOGY, 2023, 370
12345